(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement applauding the Administration’s initiative, announced today, to reduce insulin costs for Medicare enrollees: “We commend the Administration for allowing Part D plan sponsors to
In case you missed it, the Brookings Institution released a new analysis, “A Brief Look At Current Debates About Pharmacy Benefit Managers,” which provides an overview of recent legislation targeting pharmacy benefit companies being considered by Congress and how the
(Washington, D.C.) — The Health and Human Services (HHS) Office of Inspector General’s proposed rule on prescription drug rebates in Medicare and Medicaid would increase beneficiary premiums and taxpayer spending, according to a new report — “Concerns Regarding the Proposed
(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Maine consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign
In case you missed it, a new report from health policy researcher Alex Brill, founder and CEO of Matrix Global Advisors and former policy director and chief economist for the U.S. House Committee on Ways and Means, “Rebates and Drug
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a new report from IQVIA Institute for Human Data Science, 2018 and Beyond: Outlook and Turning Points. Key findings from the report include: Rebates and discounts
(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Texas consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign
Study Finds Yearly Cost of Patent Thickets on Five Top-Selling Brand Name Drugs Ranges from $1.8 to $7.6 Billion.
(Washington, D.C.) — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication
“PBMs promote competition in healthcare and help to reduce prices,” said Lawton Robert Burns Hot Off the Presses: University of Pennsylvania Wharton School professor Lawton Robert Burns releases a new book explaining the critical role pharmacy benefit companies play in
©2024 PCMA. All Rights Reserved.
